Literature DB >> 23295885

HAART: a risk factor for development of porphyria cutanea tarda?

Fred Bernardes Filho1, Maria Victória Pinto Quaresma Santos, Felipe Nazareth de Matos Pinto de Carvalho, Carlos Gustavo Carneiro de Castro, Elisabete Dobao, Marcelo Rosandiski Lyra, Vinícius de Menezes, José Augusto da Costa Nery.   

Abstract

Porphyria cutanea tarda (PCT) is caused by inherited or acquired partial deficiency of the uroporphyrinogen-decarboxylase (Uro-D) enzyme activity. It is the most common form of porphyria. The main triggering factors to the development of porphyria cutanea tarda are alcohol, hepatitis C virus and human immunodeficiency virus. There are several reports of PCT associated with drugs, among them, antiretroviral therapy. We describe three HIV-positive patients, which showed photosensitivity as well as the emergence of tense blisters on sun-exposed areas during the use of highly active antiretroviral therapy (HAART) and discuss the possibility of PCT after the use of these drugs by those patients.

Entities:  

Mesh:

Year:  2012        PMID: 23295885     DOI: 10.1590/s0037-86822012000600022

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

1.  Human Immunodeficiency Virus Associated Sporadic Nonfamilial Porphyria Cutanea Tarda.

Authors:  Sibashish Kamal Guha; Debabrata Bandyopadhyay; Abanti Saha; Niharika Ranjan Lal
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

2.  Porphyria cutanea tarda in a HIV- positive patient.

Authors:  Valéria Aparecida Zanela Franzon; Emanuella Stella Mikilita; Fernanda Henriques Camelo; Rosana Camargo
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.